2025-06-05-Bernstein-布朗-福曼公司（BF）_布朗-福曼2025财年第四季度_痛苦_11页_717kb

Brown-Forman Corp Q4F24 Results Analysis Summary

• Performance Overview: Brown-Forman Corp reported weak Q4 2024 results, with net sales down -3 organically and significantly missing consensus expectations. The miss was broad across all segments, except Emerging, due to weaker underlying demand despite a 300bps boost from distributor inventory restocking.

• Detailed Metrics: All aspects missed, including gross margins of 57.4% (a -209bps miss vs. analyst views), operating income of $513m (approx. -15% vs. consensus), and diluted EPS of $0.31 (-6% vs. forecast). Geographical breakdown shows US and International misses, while Emerging was a bright spot.

• Guidance: Forward guidance is disappointing, forecasting further organic net sales decline and operating income squeeze, citing macroeconomic volatility, consumer uncertainty, and tariff risks. Questions remain on end-demand assumptions, tariff impacts, and cost-cutting effectiveness compared to sales declines.

• Analyst Recommendation: Rating: Outperform. Price target set at $53, based on a 25x NTM+1 earnings multiple. Upside potential, but stock expected to open lower due to limited near-term growth visibility.

• Valuation: Current P/E is around 17-18x, with projections showing stable but cautiously optimistic EPS growth. EV/EBITDA metrics suggest a fair value near the target.

• Investment Risks: Downside risks include rising agave prices, slower growth in whiskey and tequila segments, and ongoing market uncertainties. Upside may hinge on inventory normalization and tariff resolution, but outlook remains cautious.

For additional details on revenue projections and supporting data, refer to the exhibits in the original report.